Abstract
Regulated expression of the recombinase RAG-1 and RAG-2 proteins is necessary for generating the vast repertoire of antigen receptors essential for adaptive immunity. Here, a retroviral cDNA library screen showed that the stress-regulated protein GADD45a activated transcription of the genes encoding RAG-1 and RAG-2 in transformed pro–B cells by a pathway requiring the transcription factor Foxo1. Foxo1 directly activated transcription of the Rag1-Rag2 locus throughout early B cell development, and a decrease in Foxo1 protein diminished the induction of Rag1 and Rag2 transcription in a model of receptor editing. We also found that transcription of Rag1 and Rag2 was repressed at the pro–B cell and immature B cell stages by the kinase Akt through its 'antagonism' of Foxo1 function. Thus, Foxo1 is a key regulator of Rag1 and Rag2 transcription in primary B cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Schatz, D.G. V(D)J recombination. Immunol. Rev. 200, 5–11 (2004).
Borghesi, L. et al. B lineage-specific regulation of V(D)J recombinase activity is established in common lymphoid progenitors. J. Exp. Med. 199, 491–502 (2004).
Grawunder, U. et al. Down-regulation of RAG1 and RAG2 gene expression in PreB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3, 601–608 (1995).
Verkoczy, L. et al. Basal B cell receptor-directed phosphatidylinositol 3-kinase signaling turns off RAGs and promotes B cell-positive selection. J. Immunol. 178, 6332–6341 (2007).
Halverson, R., Torres, R.M. & Pelanda, R. Receptor editing is the main mechanism of B cell tolerance toward membrane antigens. Nat. Immunol. 5, 645–650 (2004).
Tiegs, S.L., Russell, D.M. & Nemazee, D. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177, 1009–1020 (1993).
Geier, J.K. & Schlissel, M.S. Pre-BCR signals and the control of Ig gene rearrangements. Semin. Immunol. 18, 31–39 (2006).
Llorian, M., Stamataki, Z., Hill, S., Turner, M. & Martensson, I.L. The PI3K p110δ is required for down-regulation of RAG expression in immature B cells. J. Immunol. 178, 1981–1985 (2007).
Kuwata, N., Igarashi, H., Ohmura, T., Aizawa, S. & Sakaguchi, N. Cutting edge: absence of expression of RAG1 in peritoneal B-1 cells detected by knocking into RAG1 locus with green fluorescent protein gene. J. Immunol. 163, 6355–6359 (1999).
Rosenberg, N., Baltimore, D. & Scher, C.D. In vitro transformation of lymphoid cells by Abelson murine leukemia virus. Proc. Natl. Acad. Sci. USA 72, 1932–1936 (1975).
Muljo, S.A. & Schlissel, M.S. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines. Nat. Immunol. 4, 31–37 (2003).
Fornace, A.J. Jr, Alamo, I. Jr & Hollander, M.C. DNA damage-inducible transcripts in mammalian cells. Proc. Natl. Acad. Sci. USA 85, 8800–8804 (1988).
Zhan, Q. Gadd45a, a p53- and BRCA1-regulated stress protein, in cellular response to DNA damage. Mutat. Res. 569, 133–143 (2005).
Takekawa, M. & Saito, H. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK. Cell 95, 521–530 (1998).
Lu, B. et al. GADD45γ mediates the activation of the p38 and JNK MAP kinase pathways and cytokine production in effector TH1 cells. Immunity 14, 583–590 (2001).
Yang, J., Zhu, H., Murphy, T.L., Ouyang, W. & Murphy, K.M. IL-18-stimulated GADD45β required in cytokine-induced, but not TCR-induced, IFN-γ production. Nat. Immunol. 2, 157–164 (2001).
Chi, H., Lu, B., Takekawa, M., Davis, R.J. & Flavell, R.A. GADD45β/GADD45γ and MEKK4 comprise a genetic pathway mediating STAT4-independent IFNγ production in T cells. EMBO J. 23, 1576–1586 (2004).
Mattioni, T., Louvion, J.F. & Picard, D. Regulation of protein activities by fusion to steroid binding domains. Methods Cell Biol. 43, 335–352 (1994).
Stegmeier, F., Hu, G., Rickles, R.J., Hannon, G.J. & Elledge, S.J. A lentiviral microRNA-based system for single-copy polymerase II-regulated RNA interference in mammalian cells. Proc. Natl. Acad. Sci. USA 102, 13212–13217 (2005).
Gerwins, P., Blank, J.L. & Johnson, G.L. Cloning of a novel mitogen-activated protein kinase kinase kinase, MEKK4, that selectively regulates the c-Jun amino terminal kinase pathway. J. Biol. Chem. 272, 8288–8295 (1997).
Loots, G.G. & Ovcharenko, I. rVISTA 2.0: evolutionary analysis of transcription factor binding sites. Nucleic Acids Res. 32, W217–221 (2004).
Biggs, W.H. III, Cavenee, W.K. & Arden, K.C. Identification and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse. Mamm. Genome 12, 416–425 (2001).
Greer, E.L. & Brunet, A. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24, 7410–7425 (2005).
Coffer, P.J. & Burgering, B.M. Forkhead-box transcription factors and their role in the immune system. Nat. Rev. Immunol. 4, 889–899 (2004).
Biggs, W.H. III, Meisenhelder, J., Hunter, T., Cavenee, W.K. & Arden, K.C. Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc. Natl. Acad. Sci. USA 96, 7421–7426 (1999).
Bellacosa, A. et al. Akt activation by growth factors is a multiple-step process: the role of the PH domain. Oncogene 17, 313–325 (1998).
Hu, H. et al. Foxp1 is an essential transcriptional regulator of B cell development. Nat. Immunol. 7, 819–826 (2006).
Verkoczy, L. et al. A role for nuclear factor κB/rel transcription factors in the regulation of the recombinase activator genes. Immunity 22, 519–531 (2005).
Burgering, B.M. & Coffer, P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376, 599–602 (1995).
Billips, L.G. et al. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J. Exp. Med. 182, 973–982 (1995).
Johnson, K. et al. Regulation of immunoglobulin light-chain recombination by the transcription factor IRF-4 and the attenuation of interleukin-7 signaling. Immunity 28, 335–345 (2008).
Corcoran, A.E. et al. The interleukin-7 receptor α chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15, 1924–1932 (1996).
Venkitaraman, A.R. & Cowling, R.J. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the α chain of the interleukin-7 receptor. Eur. J. Immunol. 24, 2168–2174 (1994).
Tze, L.E. et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol. 3, e82 (2005).
Chen, J., Yusuf, I., Andersen, H.M. & Fruman, D.A. FOXO transcription factors cooperate with δEF1 to activate growth suppressive genes in B lymphocytes. J. Immunol. 176, 2711–2721 (2006).
Hsu, L.Y. et al. A conserved transcriptional enhancer regulates RAG gene expression in developing B cells. Immunity 19, 105–117 (2003).
Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885–892 (1994).
Choi, J.K., Shen, C.P., Radomska, H.S., Eckhardt, L.A. & Kadesch, T. E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J. 15, 5014–5021 (1996).
Lazorchak, A.S., Schlissel, M.S. & Zhuang, Y. E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin κ locus in pre-B cells. Mol. Cell. Biol. 26, 810–821 (2006).
Alcamo, E. et al. Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-κB in leukocyte recruitment. J. Immunol. 167, 1592–1600 (2001).
Kontgen, F. et al. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9, 1965–1977 (1995).
Sasaki, Y. et al. Canonical NF-κB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729–739 (2006).
Melamed, D. & Nemazee, D. Self-antigen does not accelerate immature B cell apoptosis, but stimulates receptor editing as a consequence of developmental arrest. Proc. Natl. Acad. Sci. USA 94, 9267–9272 (1997).
Fruman, D.A. et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α. Science 283, 393–397 (1999).
Manning, B.D. & Cantley, L.C. AKT/PKB signaling: navigating downstream. Cell 129, 1261–1274 (2007).
Lindsley, C.W. et al. Allosteric Akt (PKB) inhibitors: discovery and SAR of isozyme selective inhibitors. Bioorg. Med. Chem. Lett. 15, 761–764 (2005).
Tothova, Z. et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 128, 325–339 (2007).
Hollander, M.C. et al. Genomic instability in Gadd45a-deficient mice. Nat. Genet. 23, 176–184 (1999).
Salvador, J.M. et al. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16, 499–508 (2002).
Furuyama, T. et al. Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J. Biol. Chem. 279, 34741–34749 (2004).
Acknowledgements
We thank all who provided mice (N. Sakaguchi; Kumamoto University) and plasmid constructs (K. Murphy (University of Washington at St. Louis), A. Rao (Harvard Medical School), E. Olson (University of Texas Southwestern Medical Center), D. Fruman (University of California at Irvine), W. Sha (University of California at Berkeley), N. Rosenberg (Tufts Medical School) and G. Barton (University of California at Berkeley)); H. Nolla (Cancer Research Laboratories, University of California at Berkeley) for help with flow cytometry cell sorting; and P. Herzmark (University of California at Berkeley) for help and advice with live microscopy. Supported by the National Institutes of Health (RO1 HL48702 and RO1 AI57487 to M.S.S.).
Author information
Authors and Affiliations
Contributions
R.H.A. did all the experiments; and R.H.A. and M.S.S. jointly designed the experiments and wrote the manuscript.
Corresponding author
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–9, Supplementary Methods and Supplementary Tables 1–3 (PDF 2656 kb)
Rights and permissions
About this article
Cite this article
Amin, R., Schlissel, M. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 9, 613–622 (2008). https://doi.org/10.1038/ni.1612
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni.1612
This article is cited by
-
Altered pathways and targeted therapy in double hit lymphoma
Journal of Hematology & Oncology (2022)
-
B Cell Aberrance in Lupus: the Ringleader and the Solution
Clinical Reviews in Allergy & Immunology (2022)
-
The dynamic functions of IRF4 in B cell malignancies
Clinical and Experimental Medicine (2022)
-
Myeloid-derived suppressor cells regulate the immunosuppressive functions of PD-1−PD-L1+ Bregs through PD-L1/PI3K/AKT/NF-κB axis in breast cancer
Cell Death & Disease (2021)
-
Radiofrequency EMF irradiation effects on pre-B lymphocytes undergoing somatic recombination
Scientific Reports (2021)